Sara Vesely to Patient Selection
This is a "connection" page, showing publications Sara Vesely has written about Patient Selection.
Connection Strength
0.246
-
Rituximab for thrombotic thrombocytopenic purpura: lessons from the STAR trial. Transfusion. 2017 10; 57(10):2532-2538.
Score: 0.136
-
Methodological considerations in a community-based longitudinal study. Am J Health Behav. 2009 Jan-Feb; 33(1):58-68.
Score: 0.075
-
Consideration of older patients for enrollment in phase 1 clinical trials: Exploring treatment related toxicities and outcomes. Gynecol Oncol. 2018 04; 149(1):28-32.
Score: 0.036